2534 related articles for article (PubMed ID: 16399441)
21. [Lymph node excision in cancer of the stomach].
Msika S
J Chir (Paris); 1998 Oct; 135(4):155-61. PubMed ID: 9827394
[TBL] [Abstract][Full Text] [Related]
22. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.
Cheong O; Kim BS; Yook JH; Oh ST; Park YK; Ryu SY
J Surg Oncol; 2008 Dec; 98(7):500-4. PubMed ID: 18770520
[TBL] [Abstract][Full Text] [Related]
23. Extended lymph-node dissection for gastric cancer.
Bonenkamp JJ; Hermans J; Sasako M; van de Velde CJ; Welvaart K; Songun I; Meyer S; Plukker JT; Van Elk P; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H;
N Engl J Med; 1999 Mar; 340(12):908-14. PubMed ID: 10089184
[TBL] [Abstract][Full Text] [Related]
24. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
[TBL] [Abstract][Full Text] [Related]
25. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of D3/D4 lymph node dissection for patients with grossly N2 positive advanced gastric cancer.
Gunji Y; Suzuki T; Kobayashi S; Hori S; Hayashi H; Shimada H; Matsubara H; Nabeya Y; Ochiai T
Hepatogastroenterology; 2003; 50(52):1178-82. PubMed ID: 12846009
[TBL] [Abstract][Full Text] [Related]
27. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution.
Kasakura Y; Mochizuki F; Wakabayashi K; Kochi M; Fujii M; Takayama T
J Surg Res; 2002 Apr; 103(2):252-9. PubMed ID: 11922742
[TBL] [Abstract][Full Text] [Related]
30. Optimal surgery for advanced gastric cancer.
Songun I; van de Velde CJ
Expert Rev Anticancer Ther; 2009 Dec; 9(12):1849-58. PubMed ID: 19954295
[TBL] [Abstract][Full Text] [Related]
31. Perspectives in the treatment of gastric cancer.
Roukos DH; Kappas AM
Nat Clin Pract Oncol; 2005 Feb; 2(2):98-107. PubMed ID: 16264882
[TBL] [Abstract][Full Text] [Related]
32. Impact of spleen preservation in patients with gastric cancer.
Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM
Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561
[TBL] [Abstract][Full Text] [Related]
33. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
[TBL] [Abstract][Full Text] [Related]
34. Lymphadenectomy for gastric adenocarcinoma: should west meet east?
Yoon SS; Yang HK
Oncologist; 2009 Sep; 14(9):871-82. PubMed ID: 19738001
[TBL] [Abstract][Full Text] [Related]
35. Lymph node metastasis at the splenic hilum in proximal gastric cancer.
Ikeguchi M; Kaibara N
Am Surg; 2004 Jul; 70(7):645-8. PubMed ID: 15279191
[TBL] [Abstract][Full Text] [Related]
36. [Rational evaluation of different lymph node dissection].
Chen JQ; Wang SB; Qi CL
Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):110-3, 128. PubMed ID: 7767766
[TBL] [Abstract][Full Text] [Related]
37. Perigastric lymph node status as a prognostic indicator in patients with gastric cancer.
Adachi Y; Suematsu T; Shiraishi N; Tanimura H; Morimoto A; Kitano S
Br J Surg; 1998 Sep; 85(9):1281-4. PubMed ID: 9752878
[TBL] [Abstract][Full Text] [Related]
38. Low rates of loco-regional recurrence following extended lymph node dissection for gastric cancer.
Muratore A; Zimmitti G; Lo Tesoriere R; Mellano A; Massucco P; Capussotti L
Eur J Surg Oncol; 2009 Jun; 35(6):588-92. PubMed ID: 19162429
[TBL] [Abstract][Full Text] [Related]
39. [Recent progress in the curative surgical treatment of stomach cancer].
Gouzi JL; Pradère B; Bloom E; Julio C; Seulin P; Carrère N
Ann Chir; 1999; 53(9):874-82. PubMed ID: 10633935
[TBL] [Abstract][Full Text] [Related]
40. Extended lymphadenectomy (D2) in patients with early gastric cancer.
Nitti D; Marchet A; Mammano E; Ambrosi A; Belluco C; Mencarelli R; Maino M; Marconato G; Farinati F; Lise M
Eur J Surg Oncol; 2005 Oct; 31(8):875-81. PubMed ID: 16051460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
